Medigene AG: Publication of research on co-receptor independent MAGE-A4-specific T cell receptor
PharmiWeb,
Peer-reviewed publication in the Journal for Immunotherapy of Cancer Planegg/Martinsried (pta/30.03.2021/22:30) 30 March 2021.
Peer-reviewed publication in the Journal for Immunotherapy of Cancer Planegg/Martinsried (pta/30.03.2021/22:30) 30 March 2021.
Peer-reviewed Publikation im Journal for Immunotherapy of Cancer Planegg/Martinsried (30.03.2021) - 30.
Quelle: IRW Press Peer-reviewed Publikation im Journal for Immunotherapy of Cancer Planegg/Martinsried (30.03.2021) - 30.
Peer-reviewed Publikation im Journal for Immunotherapy of Cancer Planegg/Martinsried (30.03.2021) - 30.
Peer-reviewed Publikation im Journal for Immunotherapy of Cancer Planegg/Martinsried (30.03.2021) - 30.
Medigene AG: Wissenschaftliches Paper ?ber den Co-Rezeptor-unabh?ngigen MAGE-A4-spezifischen T-Zell-Rezeptor.
Planegg/Martinsried - 30 March 2021. Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical stage immuno-oncology…
pta20210330039 Unternehmensmitteilung für den Kapitalmarkt Peer-reviewed Publikation im Journal for Immunotherapy of Cancer…
pta20210330038 Business news for the stock market Peer-reviewed publication in the Journal for Immunotherapy of Cancer Planegg/Ma…